2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Osser Leonard | — | 1,618,577 | Sep 30, 2025 |
| Elson Marilyn | — | 1,618,577 | Sep 30, 2025 |
| Hu Ben | — | 377,095 | Sep 30, 2025 |
| Owens David | Chief Medical Officer | 191,252 | Sep 30, 2025 |
| Kazden Alan | — | 119,590 | Sep 30, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Dec 23, 2025 | White Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Van Fleet Justin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Owens David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Hu Ben | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Kazden Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2025 | Sep 30, 2025 | OSSER LEONARD | 10% Owner | Neutral | 85.0 | +83,333 | 5.43% | ✗ | - |
| Sep 29, 2025 | Sep 30, 2025 | Owens David | Chief Medical Officer | Neutral | 90.0 | +36,459 | 23.55% | ✗ | - |
| Sep 29, 2025 | Sep 30, 2025 | Hu Ben | Director | Neutral | 90.0 | +36,459 | 10.70% | ✗ | - |
| Sep 29, 2025 | Sep 30, 2025 | Kazden Alan | Director | Neutral | 90.0 | +36,459 | 43.86% | ✗ | - |
| Sep 12, 2025 | Sep 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 12, 2025 | Sep 12, 2025 | Owens David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 10, 2025 | Sep 12, 2025 | Elson Marilyn | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 7, 2025 | Van Fleet Justin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 17, 2025 | Jul 21, 2025 | Elson Marilyn | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2025 | Mar 13, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy | 91.3 | +6,000 | 25.00% | ✗ | $13.2K |
| Feb 26, 2025 | Feb 27, 2025 | White Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2025 | Feb 27, 2025 | Owens David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 14, 2024 | Feb 10, 2025 | Shelton Carolyn Hamby | Senior VP | Buy | 91.3 | +24,000 | 100.00% | ✗ | $20.4K |
| Feb 4, 2025 | Feb 5, 2025 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.65% | ✗ | $3.1K |
| Feb 4, 2025 | Feb 4, 2025 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.65% | ✗ | $3K |
| Dec 20, 2024 | Jan 29, 2025 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.67% | ✗ | $2.8K |
| Nov 2, 2024 | Jan 29, 2025 | Kazden Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 29, 2025 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,500 | 0.98% | ✗ | $4.1K |
| Jan 13, 2025 | Jan 24, 2025 | Owens David | Chief Medical Officer | Buy | 77.5 | +3,000 | 2.01% | ✗ | $7.7K |
| Oct 28, 2024 | Oct 30, 2024 | Owens David | Chief Medical Officer | Buy | 60.0 | +500 | 0.34% | ✗ | $1.1K |
| Sep 30, 2024 | Oct 2, 2024 | Elson Marilyn | 10% Owner | Neutral | 90.0 | +700,000 | 83.81% | ✗ | - |
| Sep 30, 2024 | Oct 2, 2024 | Bernhard Leslie | Director | Neutral | 90.0 | +49,838 | 100.00% | ✗ | - |
| Sep 30, 2024 | Oct 2, 2024 | Hu Ben | Director | Neutral | 90.0 | +175,000 | 105.65% | ✗ | - |
| Sep 23, 2024 | Sep 25, 2024 | Elson Marilyn | 10% Owner | Neutral | 90.0 | +700,000 | 83.81% | ✗ | - |
| Sep 28, 2022 | Sep 25, 2024 | Elson Marilyn | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |